4808 studies found for:    "Liver Diseases"
Show Display Options
Rank Status Study
21 Recruiting Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease
Conditions: Cystic Fibrosis;   Liver Disease
Intervention:
22 Not yet recruiting Study of Peripheral Tissue Oxygenation in End-stage Liver Disease Patients During Liver Transplantation
Condition: End Stage Liver Disease
Intervention:
23 Completed
Has Results
Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease
Conditions: Thrombocytopenia;   Liver Diseases
Interventions: Drug: eltrombopag 12.5 milligrams (mg) tablet;   Drug: eltrombopag 25 mg tablet
24 Recruiting Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis
Conditions: Alcoholic Fatty Liver Disease;   Alcoholic Hepatitis
Interventions: Drug: Placebo /bid P.O;   Drug: MG-1;   Drug: MG-2 : MG1000mg, Placebo /bid P.O;   Drug: metadoxine
25 Recruiting Use of Omega-3 Fat Emulsion (Omegaven) in Infants With Parenteral Nutrition Associated Liver Disease
Condition: Parenteral Nutrition Associated Liver Disease
Intervention: Drug: Omegaven
26 Completed Once-Daily Oral E5501 Tablets Used in Subjects With Chronic Liver Diseases and Thrombocytopenia Prior to Elective Surgical or Diagnostic Procedures
Condition: Thrombocytopenia Related to Chronic Liver Disease
Interventions: Drug: E5501;   Drug: Placebo
27 Unknown  The Connection Between Liver Disease and Chitinase Proteins
Condition: Liver Disease
Intervention: Other: A blood test
28 Completed
Has Results
Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD)
Condition: Liver Diseases
Intervention:
29 Recruiting A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation
Conditions: Liver Diseases;   Hepatocellular Cancer;   Endstage Liver Disease;   Liver Cirrhosis
Intervention: Behavioral: donor pain management/ Pre-operative OR Set-up
30 Recruiting Adult-to-Adult Living Donor Transplant Cohort Study
Conditions: Liver Diseases;   Hepatocellular Cancer;   End Stage Liver Disease;   Hepatitis C;   Liver Cirrhosis
Intervention:
31 Recruiting Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2
Condition: Liver Disease
Intervention:
32 Completed Relative-dose-response Test (RDR) Adaptation for Chronic Liver Disease
Condition: Chronic Liver Disease
Intervention: Dietary Supplement: retinyl palmitate (UNICEF, Melbourne, Australia)
33 Completed Polymorphisms of Fibrosis-Relating Genes on Outcome of HCV-Related Chronic Liver Disease
Conditions: Fibrosis;   Chronic Liver Disease
Interventions: Genetic: cytokine;   Genetic: cytokine polymorphisms;   Genetic: cytokine polymorphism
34 Recruiting Genetic Studies of Non-Alcoholic Fatty Liver Disease
Conditions: Fatty Liver;   Liver Cirrhosis;   Non-Alcoholic Fatty Liver Disease;   Liver Transplantation;   Genetics
Intervention:
35 Terminated
Has Results
Polycystic Liver Disease in Kidney Transplant
Condition: Polycystic Liver Disease
Interventions: Drug: Tacrolimus;   Drug: Sirolimus;   Drug: Mycophenolate Mofetil;   Drug: Prednisone
36 Completed The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease
Condition: Non Alcoholic Fatty Liver Disease
Interventions: Drug: Omacor;   Drug: lactose tablet
37 Unknown  Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease
Condition: Non-alcoholic Fatty Liver Disease
Intervention: Procedure: Phlebotomy
38 Recruiting Ultrasound Method to Measure Fibrosis of the Liver in Children
Conditions: Chronic Liver Disease;   Non-Alcoholic Fatty Liver Disease;   HCV Coinfection;   HBV;   Drug-Induced Liver Injury
Intervention: Device: Shear Wave sonoelastography
39 Unknown  Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease
Condition: Non-Alcoholic Fatty Liver Disease
Interventions: Drug: Lovaza;   Drug: placebo control
40 Completed The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver Disease
Condition: Non-alcoholic Fatty Liver Disease
Intervention: Dietary Supplement: Efamax

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years